Disclaimer

Introduction

Please read this Disclaimer carefully before using Top8forweightloss.com (the "Website"). This Website is owned and operated by Top8forweightloss ("Top8forweightloss," "us," "we," "our"). This Disclaimer contains important information regarding limitations of our liability. By accessing or using the Website, you agree to be bound by this Disclaimer. If you disagree with any part, you do not have our permission to access or use the Website.

Not Medical Advice

Top8forweightloss.com is an informational comparison website. We are not a healthcare provider, telehealth service, or pharmacy. All content on this Website is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment.

We do not:

• Provide medical, health, or professional advice
• Diagnose, treat, or cure any medical condition
• Prescribe medications or recommend specific treatments
• Collect protected health information (PHI) as defined by HIPAA
• Act as a healthcare provider or telehealth service

Always consult with a qualified healthcare professional before making decisions about your health, weight loss, or medical treatments. Never disregard professional medical advice or delay seeking it because of something you read on this Website. Top8forweightloss is not responsible for any actions taken based on the information provided on our platform.

GLP-1 Medications and FDA Status

This Website covers GLP-1 receptor agonist medications, including semaglutide and tirzepatide. These medications have different regulatory statuses depending on how they are manufactured and distributed:

Brand-name medications such as Wegovy®, Zepbound®, Ozempic®, and Mounjaro® are FDA-approved for specific indications. Wegovy® and Zepbound® are approved for chronic weight management. Ozempic® and Mounjaro® are approved for Type 2 diabetes and are sometimes prescribed off-label for weight loss. FDA approval means these medications have been evaluated for safety and effectiveness through clinical trials.

Compounded medications containing semaglutide or tirzepatide are NOT FDA-approved. They have not been evaluated by the FDA for safety, effectiveness, or quality. Compounded medications are not brand-name drugs, nor are they considered generics. They are prepared by state-licensed compounding pharmacies, but "state-licensed" is not the same as "FDA-approved." The FDA has declared the shortage of semaglutide and tirzepatide resolved, which means compounded versions face increased regulatory scrutiny.

All GLP-1 medications, whether brand-name or compounded, require a prescription from a licensed healthcare provider. Talk to your doctor about whether any GLP-1 medication is appropriate for your medical history and health goals.

Side Effects and Risks

GLP-1 medications have been associated with a range of side effects. Some of the more commonly reported ones include nausea, vomiting, diarrhea, constipation, abdominal pain, and reduced appetite. More serious side effects, though less common, have included pancreatitis, gallbladder complications, kidney problems, and severe gastrointestinal reactions.

FDA-approved labeling for GLP-1 receptor agonists includes a boxed warning: these medications should NOT be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

This is not a complete list of side effects. We are not a medical provider, and the information above is included for educational and informational purposes only. It is based on publicly available FDA labeling and medical literature. Individual experiences vary. If you experience any side effects from any medication, contact a licensed healthcare provider immediately.

Affiliate Relationships and Advertising

Top8forweightloss participates in affiliate marketing programs with third-party telehealth providers, healthcare services, and weight loss programs. We earn fees when you click on links to these providers or sign up through our Website. This compensation may influence which offers are displayed and how they appear on the page.

Compensation may influence which offers appear and how they are positioned, but it does not change how we write about a provider. We apply the same evaluation standards to all providers regardless of whether they are advertising partners. For more details, see our Editorial Policy and Advertiser Disclosure.

Pricing Information

Pricing displayed on this Website is provided for informational purposes and may not reflect current rates. GLP-1 medication pricing changes frequently due to promotional offers, dose escalation, insurance plan variations, and provider policy updates. We verify pricing against provider websites and, in some cases, by contacting providers directly. However, we cannot guarantee that prices shown are current at the time you view them.

When pricing differs between a first month and ongoing months, we disclose both. Always confirm current pricing directly with the provider before enrolling. Each review page notes when pricing was last verified.

Third-Party Healthcare Providers

The healthcare providers, telehealth services, and weight loss programs listed on our site are independent third parties. We do not control, monitor, or endorse these providers. Each provider is solely responsible for:

• Their own privacy practices and HIPAA compliance
• The collection, use, and protection of your health information
• The medical services, treatments, and advice they provide
• The quality, safety, or effectiveness of any treatments or medications
• Compliance with all applicable healthcare regulations

When you click on links to third-party providers and leave our Website, you are subject to the terms, conditions, and privacy policies of those third-party websites. We are not responsible for anything that happens on third-party websites. Review each provider's privacy policy, terms of service, and medical disclaimers before engaging with their services or providing any personal or health information.

Geographic Restrictions

Top8forweightloss is based in the United States. Our platform is intended exclusively for users in the United States. We do not provide services to users outside of the United States. Availability, pricing, and insurance coverage of products and services featured on this Website vary by state and plan. Licensed healthcare providers determine eligibility, medication selection, dosing, and treatment format based on your location and individual circumstances.

Email Communications

If you have subscribed to our newsletter or other email communications, you can unsubscribe at any time by clicking the unsubscribe link included in every email, or by visiting our unsubscribe page.

Trademarks

All brand names, trademarks, and service marks mentioned on this Website, including but not limited to Wegovy®, Ozempic®, Zepbound®, Mounjaro®, and Saxenda®, are the property of their respective owners. Their use on this Website is for identification and informational purposes only and does not imply endorsement by or affiliation with the trademark holders.

Changes to This Disclaimer

We reserve the right to amend this Disclaimer at any time. We will notify you of material changes by posting the updated Disclaimer on this page with a new "Last Updated" date. Your continued use of the Website after any changes constitutes your acceptance of the updated Disclaimer.

Contact Us

If you have any questions, concerns, or requests regarding this Disclaimer or our practices, please contact us: